John Paulson's Strategic Moves: A Closer Look at Perpetua Resources Corp

Insights from the Second Quarter 2025 13F Filing

John Paulson (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. John Paulson (Trades, Portfolio) is the President and Portfolio Manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the 3rd largest hedge fund in the world managing approximately $29 billion in merger, event, and distressed strategies. Mr. Paulson received his Masters of Business Administration with high distinction, as a Baker Scholar, from Harvard Business School in 1980. He graduated summa cum laude in Finance from New York University's College of Business and Public Administration in 1978. Prior to forming Paulson in 1994, John was a general partner of Gruss Partners and a managing director in mergers and acquisitions at Bear Stearns. John Paulson (Trades, Portfolio), a former mergers and acquisitions banker, established his firm as a merger arbitrage hedge fund manager, seeking to make money from situations when one public company announces plans to take over another. Merger arbitrage hedge funds primarily study equity markets, but they also research the market for credit default swaps, a form of insurance that starts paying out as soon as a credit security falls in value.

Warning! GuruFocus has detected 6 Warning Signs with MDGL.John Paulson's Strategic Moves: A Closer Look at Perpetua Resources Corp

Summary of New Buy

John Paulson (Trades, Portfolio) added a total of 2 stocks, among them:

The most significant addition was Juniper Networks Inc (JNPR), with 250,000 shares, accounting for 0.5% of the portfolio and a total value of $9.98 million. The second largest addition to the portfolio was Alphabet Inc (NASDAQ:GOOG), consisting of 9,000 shares, representing approximately 0.08% of the portfolio, with a total value of $1.60 million.

Key Position Increases

John Paulson (Trades, Portfolio) also increased stakes in a total of 2 stocks, among them:

The most notable increase was Perpetua Resources Corp (NASDAQ:PPTA), with an additional 7,575,757 shares, bringing the total to 32,347,299 shares. This adjustment represents a significant 30.58% increase in share count, a 4.57% impact on the current portfolio, with a total value of $392.70 million. The second largest increase was Bausch Health Companies Inc (NYSE:BHC), with an additional 6,352,667 shares, bringing the total to 32,791,702. This adjustment represents a significant 24.03% increase in share count, with a total value of $218.39 million.

Summary of Sold Out

John Paulson (Trades, Portfolio) completely exited 1 holding in the second quarter of 2025, as detailed below:

Story Continues

Intra-Cellular Therapies Inc (ITCI): John Paulson (Trades, Portfolio) sold all 21,500 shares, resulting in a -0.16% impact on the portfolio.

Key Position Reduces

John Paulson (Trades, Portfolio) also reduced his position in 1 stock. The most significant changes include:

Reduced Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 10,000 shares, resulting in a -0.48% decrease in shares and a -0.19% impact on the portfolio. The stock traded at an average price of $298.48 during the quarter and has returned 26.58% over the past 3 months and 19.71% year-to-date.

Portfolio Overview

At the second quarter of 2025, John Paulson (Trades, Portfolio)'s portfolio included 15 stocks, with top holdings including 31.44% in Madrigal Pharmaceuticals Inc (NASDAQ:MDGL), 19.53% in Perpetua Resources Corp (NASDAQ:PPTA), 15.68% in Acadian Asset Management Inc (NYSE:AAMI), 10.86% in Bausch Health Companies Inc (NYSE:BHC), and 5.54% in Novagold Resources Inc (NG).John Paulson's Strategic Moves: A Closer Look at Perpetua Resources Corp

The holdings are mainly concentrated in 6 of the 11 industries: Healthcare, Basic Materials, Financial Services, Communication Services, Industrials, and Technology.John Paulson's Strategic Moves: A Closer Look at Perpetua Resources Corp

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

This article first appeared on GuruFocus.

View Comments